Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody.

The global Orencia (abatacept) Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Orencia (abatacept) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orencia (abatacept) Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Orencia (abatacept) Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Orencia (abatacept) Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bristol-Myers Squibb
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Prefilled Syringe
Vial

Segment by Application
Rheumatoid Arthritis
Psoriatic Arthritis
Other